Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond. (Q36791537)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2007

Language	Label	Description	Also known as
English	Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond.	scientific article published on January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

chronic myeloid leukemia

0 references

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Jiong Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Zhen-Yi Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sai-Juan Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Zhu Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Advances in Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

191-220

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

All-trans retinoic acid in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecularly targeted therapy in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards combination target-directed chemotherapy for chronic myeloid leukemia: role of farnesyl transferase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Arsenic trioxide: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular genetics of human leukemias: new insights into therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The molecular basis of leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of FLT3 in leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Single cell profiling of potentiated phospho-protein networks in cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics of myeloid leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the histone deacetylase complex in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative importance of apoptosis and cell cycle blockage in the synergistic effect of combined R115777 and imatinib treatment in BCR/ABL-positive cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

FLT3 and its Role in the Pathogenesis of Acute Myeloid Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Series introduction. JAK-STAT signaling in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Flt3 receptor tyrosine kinase as a drug target in leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overriding imatinib resistance with a novel ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute promyelocytic leukemia as a paradigm for targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ham-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The BCR-ABL story: bench to bedside and back

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of an acquired JAK2 mutation in polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoic acid and arsenic for treating acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

How acute promyelocytic leukaemia revived arsenic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A sumoylation site in PML/RARA is essential for leukemic transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2998006-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0065-230X(06)98006-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17433911%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36791537&oldid=1527088275"